Form D · Other Health Care
Quantagen Biotech Inc
Boca Raton, FL · CIK 0001522697
Offering snapshot reported Jun 14, 2011 · SEC filing
- Reported sold
- $11.5K Indefinite offering
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $500 Reported outside-investor minimum
- First sale
- Oct 19, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 14, 2011 | Initial | $11,500 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-161205
Source: Form D, filed Jun 14, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ayme Harrison | Director, Executive |
| David Hostelley | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
200 Glades Road Suite 3
Boca Raton, FL, 33432
Boca Raton, FL, 33432